Dysregulation of the Norepinephrine Transporter Sustains Cortical Hypodopaminergia and Schizophrenia-Like Behaviors in Neuronal Rictor Null Mice

A novel animal model highlights the link between Akt dysfunction, reduced cortical dopamine function, norepinephrine transporters, and schizophrenia-like behaviors.

• Publication year

  2010

• Venue

  PLoS Biology

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1371/journal.pbio.1000393PMID 20543991PMCID 2882427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals.

  2011cited by this paper
• Akt/GSK3 signaling in the action of psychotropic drugs.

  2009cited by this paper
• A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.

  2009cited by this paper
• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• The dopamine hypothesis of schizophrenia: version III--the final common pathway.

  2009influential reference
• Prepulse inhibition and genetic mouse models of schizophrenia.

  2009cited by this paper
• AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.

  2008cited by this paper
• Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk

  2008cited by this paper
• AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.

  2008cited by this paper
• Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.

  2008influential reference
• Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling

  2008cited by this paper
• Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims.

  2007cited by this paper
• Neuregulin-1 Regulates Cell Adhesion via an ErbB2/Phosphoinositide-3 Kinase/Akt-Dependent Pathway: Potential Implications for Schizophrenia and Cancer

  2007influential reference
• Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex

  2007cited by this paper
• Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via P13K/AKT, ERK, and pertussis toxin-sensitive pathways

  2007cited by this paper
• Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.

  2006cited by this paper
• Norepinephrine Transporter Blockade can Normalize the Prepulse Inhibition Deficits Found in Dopamine Transporter Knockout Mice

  2006cited by this paper
• Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.

  2006influential reference
• Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning

  2006cited by this paper
• SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

  2006cited by this paper
• Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation.

  2006cited by this paper
• Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia

  2006cited by this paper
• Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.

  2005cited by this paper
• Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members.

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Dopamine in the Medial Prefrontal Cortex Controls Genotype-Dependent Effects of Amphetamine on Mesoaccumbens Dopamine Release and Locomotion

  2004cited by this paper
• Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

  2004influential reference
• The effects of clozapine on the GSK‐3‐mediated signaling pathway

  2004cited by this paper
• Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals

  2003influential reference
• Norepinephrine in the Prefrontal Cortex Is Critical for Amphetamine-Induced Reward and Mesoaccumbens Dopamine Release

  2003cited by this paper
• Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals.

  2003cited by this paper
• Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.

  2003cited by this paper
• Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines

  2002influential reference
• PI 3‐kinase regulation of dopamine uptake

  2002cited by this paper
• Prepulse Inhibition Deficits and Perseverative Motor Patterns in Dopamine Transporter Knock-Out Mice: Differential Effects of D1 and D2 Receptor Antagonists

  2001cited by this paper
• Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals

  2000cited by this paper
• The Dopamine D2, but not D3 or D4, Receptor Subtype is Essential for the Disruption of Prepulse Inhibition Produced by Amphetamine in Mice

  1999cited by this paper
• Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.

  1999cited by this paper
• Regulation of Extracellular Dopamine by the Norepinephrine Transporter

  1998cited by this paper
• Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study.

  1996cited by this paper
• Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.

  1995cited by this paper
• Local Influence of Endogenous Norepinephrine on Extracellular Dopamine in Rat Medial Prefrontal Cortex

  1995cited by this paper
• Deficient Sensorimotor Gating After 6‐Hydroxydopamine Lesion of the Rat medial Prefrontal Cortex is Reversed by Haloperidol

  1994cited by this paper
• The effect of insulin on norepinephrine uptake by PC12 cells.

  1993cited by this paper
• Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus.

  1993cited by this paper
• Dopamine in schizophrenia: a review and reconceptualization.

  1991cited by this paper
• Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity.

  1988cited by this paper
• Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

  1988cited by this paper
• Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain.

  1986cited by this paper
• Schizophrenia: elevated cerebrospinal fluid norepinephrine.

  1980cited by this paper
• The dopamine hypothesis of schizophrenia: focus on the dopamine receptor.

  1976cited by this paper
• Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.

  1975cited by this paper
• Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

  1973cited by this paper
• [Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)].

  1952cited by this paper

• The mammalian/mechanistic target of rapamycin complex 2 and its role in nervous system

  2025cites this paper
• Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia

  2025cites this paper
• Whole transcriptome sequencing to uncover CircRNA expression patterns linked to schizophrenia pathogenesis

  2025cites this paper
• RICTOR variants are associated with neurodevelopmental disorders

  2024cites this paper
• Targeting spinal mechanistic target of rapamycin complex 2 alleviates inflammatory and neuropathic pain

  2024cites this paper
• Adolescent stress differentially modifies dopamine and norepinephrine release in the medial prefrontal cortex of adult rats.

  2024cites this paper
• Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain

  2023cites this paper
• Hog1 acts in a Mec1-independent manner to counteract oxidative stress following telomerase inactivation in Saccharomyces cerevisiae

  2023cites this paper
• mTORC2 mediates structural plasticity in distal nociceptive endings that contributes to pain hypersensitivity following inflammation

  2022cites this paper
• Schizophrenia Hypothesis: Autonomic Nervous System Dysregulation of Fetal and Adult Immune Tolerance

  2022cites this paper
• Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia

  2022cites this paper
• Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2

  2021cites this paper
• Alteration in the mRNA expression profile of the autophagy-related mTOR pathway in schizophrenia patients treated with olanzapine

  2021cites this paper
• Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly

  2021cites this paper
• Proteome Analysis of PC12 Cells Reveals Alterations in Translation Regulation and Actin Signaling Induced by Clozapine

  2021cites this paper
• 18F-meta-fluorobenzylguanidine (18F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models

  2020cites this paper
• Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia

  2020cites this paper
• Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent.

  2020cites this paper
• The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction

  2020cites this paper
• Insights into Potential Targets for Therapeutic Intervention in Epilepsy

  2020cites this paper
• Maternal immune activation impairs cognitive flexibility and alters transcription in frontal cortex.

  2019cites this paper
• The role of norepinephrine in the pathophysiology of schizophrenia.

  2019cites this paper
• Gene Knock Up via 3’UTR editing to study gene function in vivo

  2019cites this paper
• Multi-omics analysis identifies mitochondrial pathways associated with anxiety-related behavior

  2019cites this paper
• Positive allosteric modulation of metabotropic glutamate receptor 5 modulates Akt and GSK3β signaling in vivo

  2019cites this paper
• [Research advances in the role of mTOR signaling pathway in autism spectrum disorder].

  2019influential citation
• Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration

  2018cites this paper
• Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging

  2018cites this paper
• Interference of norepinephrine transporter trafficking motif attenuates amphetamine‐induced locomotor hyperactivity and conditioned place preference

  2018cites this paper
• mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders

  2018cites this paper
• Early Combination Therapy for Type 2 Diabetes Mellitus and Common Comorbid Mental Disorders.

  2018cites this paper
• Deletion of Rictor in catecholaminergic neurons alters locomotor activity and ingestive behavior

  2017influential citation
• Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination

  2017cites this paper
• Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies

  2017cites this paper
• Molecular neurobiology of mTOR.

  2017cites this paper
• Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs.

  2017cites this paper
• Identification of candidate genes involved in the etiology of sporadic Tourette syndrome by exome sequencing

  2017cites this paper
• Recovery-oriented Medical Training: A Narrative Literature Review for the University of Recovery as a New Concept of Co-learning between Patients and (Future) Healthcare Providers

  2017cites this paper
• Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters

  2016cites this paper
• Evolution of the Protein Synthesis Machinery and Its Regulation

  2016cites this paper
• Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.

  2016cites this paper
• Evolution of TOR and Translation Control

  2016cites this paper
• Animal Models: Citations

  2016cites this paper
• Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex.

  2016cites this paper
• Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study.

  2016cites this paper
• Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease

  2016cites this paper
• Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.

  2016cites this paper
• mTOR in Brain Physiology and Pathologies.

  2015cites this paper
• mTORC2/Rictor Signaling Disrupts Dopamine-Dependent Behaviors via Defects in Striatal Dopamine Neurotransmission

  2015influential citation
• Tricornered Kinase Regulates Synapse Development by Regulating the Levels of Wiskott-Aldrich Syndrome Protein

  2015cites this paper
• Genetic association of ACSM1 variation with schizophrenia and major depressive disorder in the Han Chinese population

  2015cites this paper
• Brain without Rictor: mTORC2 Signaling Regulates Central Dopamine Homeostasis

  2015influential citation
• Intervention in the Context of Development: Pathways Toward New Treatments

  2015cites this paper
• Association Study between Norepinephrine Transporter Gene Polymorphism and Schizophrenia in a Korean Population

  2015cites this paper
• Impaired mTORC2 signaling in catecholaminergic neurons exaggerates high fat diet-induced hyperphagia

  2015cites this paper
• A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference*

  2015influential citation
• mTOR signaling in tumorigenesis.

  2014cites this paper
• Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis

  2014cites this paper
• The neurology of mTOR.

  2014cites this paper
• The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.

  2014cites this paper
• Is the mTOR‐signalling cascade disrupted in Schizophrenia?

  2014cites this paper
• Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

  2014cites this paper
• EFFECT OF DIABETES AND SCHIZOPHRENIA ON COGNITIVE FUNCTION IN EGYPTIANS

  2013influential citation
• The identification of dysfunctional crosstalk of pathways in Parkinson disease.

  2013cites this paper
• Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex.

  2013influential citation
• Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice.

  2013cites this paper
• Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology

  2013cites this paper
• Animal model of Wolfram Syndrome in mice: behavioural, biochemical and psychopharmacological characterization

  2013cites this paper
• mTORC2 controls actin polymerization required for consolidation of long-term memory

  2013cites this paper
• De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder

  2013cites this paper
• Nonaggressive and adapted social cognition is controlled by the interplay between noradrenergic and nicotinic receptor mechanisms in the prefrontal cortex

  2013cites this paper
• mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development

  2013cites this paper
• Modulation of basal ganglia function by metabotropic glutamate receptors

  2013cites this paper
• mTOR complexes in neurodevelopmental and neuropsychiatric disorders

  2013cites this paper
• Insulin and the brain.

  2013cites this paper
• A recollection of mTOR signaling in learning and memory.

  2013cites this paper
• mTORC2 controls neuron size and Purkinje cell morphology independent of mTORC1

  2012cites this paper
• mTORC 2 controls neuron size and Purkinje cell morphology independent of mTORC 1

  2012cites this paper
• Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake

  2012cites this paper
• Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice.

  2012influential citation
• Paying attention to the details: Rare genetic variation in the dopamine transporter and ADHD

  2012cites this paper
• Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

  2012cites this paper
• Mammalian Target of Rapamycin

  2012cites this paper
• Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing

  2012cites this paper
• The role of raptor during brain development and in adult forebrain neurons

  2012cites this paper
• Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat.

  2012cites this paper
• Insulin signaling and addiction.

  2011cites this paper
• Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.

  2011cites this paper
• Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.

  2011cites this paper
• An emerging role for TOR signaling in mammalian tissue and stem cell physiology

  2011influential citation
• Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs

  2011cites this paper
• Cocaine Up-regulation of the Norepinephrine Transporter Requires Threonine 30 Phosphorylation by p38 Mitogen-activated Protein Kinase*

  2011cites this paper
• Regulation of monoamine transporters: Role of transporter phosphorylation.

  2011influential citation
• mTOR complex 2 signaling and functions

  2011cites this paper
• Caractérisations biochimique anatomique et comportementale des souris dépourvues de la protéines STOP : un modèle expérimental pour l'étude de symptômes psycho-affectifs

  2011cites this paper
• DISC1 in schizophrenia: genetic mouse models and human genomic imaging.

  2011cites this paper
• Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape

  2011cites this paper
• Insulin Reveals Akt Signaling as a Novel Regulator of Norepinephrine Transporter Trafficking and Norepinephrine Homeostasis

  2010cites this paper